NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)

The National Institutes of Health (NIH) is seeking applications for the NHLBI Outstanding Investigator Award (OIA), which aims to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators. The award will support a research program for up to seven years and provide investigators with increased freedom to conduct research that breaks new ground or extends previous discoveries in new directions. The research must be within the scope of the NHLBI mission, which includes heart, lung, blood, and sleep research. Key aspects of the award include: • Providing a stable funding environment to improve productivity and facilitate innovative research • Allowing flexibility in pursuing new research directions as they arise • Reducing the time researchers spend writing grant applications and managing multiple grant awards • Facilitating commitment to research through increased stability of funding • Enabling researchers to devote more time and energy to mentoring students and junior scientists and providing scientific service.